ARDS OTC
Aridis Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -50.0%
1Y: -92.3%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$20M
Revenue
+2227.6% YoY
$-1M
Net Income
+96.8% YoY
$-18M
Free Cash Flow
+26.2% YoY
100.0%
Gross Margin
-208.4%
Op. Margin
-19.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE4.8%
ROA-12.2%
ROIC10.0%
Valuation
P/E-0.0
P/B-0.0
EV/EBITDA-15.0
Leverage
Debt/Equity-0.41
Current Ratio0.24
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z-40.51
Beneish M0.00